Benchmark reaffirmed their buy rating on shares of Plexus (NASDAQ:PLXS – Free Report) in a research note released on Monday,Benzinga reports. They currently have a $220.00 price target on the technology company’s stock.
Several other research analysts have also commented on the company. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Needham & Company LLC raised their price objective on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Stifel Nicolaus lifted their target price on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Williams Trading set a $195.00 target price on Plexus in a research report on Wednesday, January 28th. Finally, Weiss Ratings upgraded Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $194.20.
Check Out Our Latest Analysis on PLXS
Plexus Price Performance
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.07 billion. During the same period last year, the company posted $1.73 EPS. The business’s revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Sell-side analysts forecast that Plexus will post 5.9 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CEO Todd P. Kelsey sold 5,231 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $195.78, for a total transaction of $1,024,125.18. Following the transaction, the chief executive officer owned 83,291 shares of the company’s stock, valued at approximately $16,306,711.98. This represents a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Patrick John Jermain sold 2,321 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $201.12, for a total value of $466,799.52. Following the completion of the sale, the chief financial officer owned 14,561 shares in the company, valued at approximately $2,928,508.32. The trade was a 13.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 47,995 shares of company stock worth $9,718,476 over the last three months. 1.78% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Plexus
Large investors have recently bought and sold shares of the business. AQR Capital Management LLC increased its stake in Plexus by 103.1% in the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after purchasing an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Plexus by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after purchasing an additional 705 shares during the period. United Services Automobile Association bought a new position in shares of Plexus in the first quarter worth about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Plexus by 12.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after purchasing an additional 9,078 shares during the last quarter. Finally, Bank of Montreal Can increased its stake in Plexus by 4.0% in the 2nd quarter. Bank of Montreal Can now owns 4,488 shares of the technology company’s stock worth $607,000 after buying an additional 172 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
